Challenges and implications of anti-JCV antibody serology variability among different assays in natalizumab treatment: A call for standardization and transparency in clinical practice

Multiple Sclerosis

Jahr

Publikationsjahr
2024

Autoren

Autorenliste der Publikation
Inojosa H, Kather A, Akgün K, Ziemssen T.

Verlag

Publisher-Information
Mult Scler. 2024 Nov 23:13524585241300972.

Link

Zur Publikation (externer Server)
https://doi.org/10.1177/13524585241300972

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
MSZTreatments2024